Literature DB >> 18768857

Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation.

Guo-Min Deng1, George C Tsokos.   

Abstract

Infectious agents, including bacteria and viruses, are thought to provide triggers for the development or exacerbation of autoimmune diseases such as systemic lupus erythematosus in the genetically predisposed individual. Molecular mimicry and engagement of TLRs have been assigned limited roles that link infection to autoimmunity, but additional mechanisms are suspected to be involved. In this study we show that T cells from lupus-prone mice display aggregated lipid rafts that harbor signaling, costimulatory, inflammatory, adhesion, and TLR molecules. The percentage of T cells with clustered lipid rafts increases with age and peaks before the development of lupus pathology. We show that cholera toxin B, a component of Vibrio cholerae, promotes autoantibody production and glomerulonephritis in lupus-prone mice by enhancing lipid raft aggregation in T cells. In contrast, disruption of lipid raft aggregation results in delay of disease pathology. Our results demonstrate that lipid rafts contribute significantly to the pathogenesis of lupus and provide a novel mechanism whereby aggregated lipid rafts represent a potential link between infection and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768857      PMCID: PMC2556981          DOI: 10.4049/jimmunol.181.6.4019

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

Review 1.  Raft trafficking of AB5 subunit bacterial toxins.

Authors:  Wayne I Lencer; David Saslowsky
Journal:  Biochim Biophys Acta       Date:  2005-08-15

2.  Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry.

Authors:  Micah T McClain; Latisha D Heinlen; Gregory J Dennis; Jon Roebuck; John B Harley; Judith A James
Journal:  Nat Med       Date:  2004-12-26       Impact factor: 53.440

3.  The initiation of antigen-induced B cell antigen receptor signaling viewed in living cells by fluorescence resonance energy transfer.

Authors:  Pavel Tolar; Hae Won Sohn; Susan K Pierce
Journal:  Nat Immunol       Date:  2005-10-02       Impact factor: 25.606

4.  Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis.

Authors:  Volker Vielhauer; George Stavrakis; Tanya N Mayadas
Journal:  J Clin Invest       Date:  2005-04-01       Impact factor: 14.808

5.  Pathogenesis of autoimmunity in alphabeta T cell-deficient lupus-prone mice.

Authors:  S L Peng; J Cappadona; J M McNiff; M P Madaio; M J Owen; A C Hayday; J Craft
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

6.  Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice.

Authors:  Y Tada; K Nagasawa; A Ho; F Morito; S Koarada; O Ushiyama; N Suzuki; A Ohta; T W Mak
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

7.  PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus.

Authors:  Domingo F Barber; Almira Bartolomé; Carmen Hernandez; Juana M Flores; Clara Redondo; Cristina Fernandez-Arias; Montserrat Camps; Thomas Rückle; Matthias K Schwarz; Santiago Rodríguez; Carlos Martinez-A; Dimitrios Balomenos; Christian Rommel; Ana C Carrera
Journal:  Nat Med       Date:  2005-08-28       Impact factor: 53.440

8.  IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.

Authors:  A Schwarting; T Wada; K Kinoshita; G Tesch; V R Kelley
Journal:  J Immunol       Date:  1998-07-01       Impact factor: 5.422

9.  T lymphocyte costimulation mediated by reorganization of membrane microdomains.

Authors:  A Viola; S Schroeder; Y Sakakibara; A Lanzavecchia
Journal:  Science       Date:  1999-01-29       Impact factor: 47.728

Review 10.  Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic.

Authors:  N A Williams; T R Hirst; T O Nashar
Journal:  Immunol Today       Date:  1999-02
View more
  41 in total

Review 1.  T cells as therapeutic targets in SLE.

Authors:  José C Crispín; Vasileios C Kyttaris; Cox Terhorst; George C Tsokos
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

2.  T cell activation by terminal complex of complement and immune complexes.

Authors:  Anil K Chauhan; Terry L Moore
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

Review 3.  Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective.

Authors:  Vaishali R Moulton; Abel Suarez-Fueyo; Esra Meidan; Hao Li; Masayuki Mizui; George C Tsokos
Journal:  Trends Mol Med       Date:  2017-06-13       Impact factor: 11.951

Review 4.  Metabolic Factors that Contribute to Lupus Pathogenesis.

Authors:  Wei Li; Ramya Sivakumar; Anton A Titov; Seung-Chul Choi; Laurence Morel
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

5.  Lipid rafts are required for effective renal D1 dopamine receptor function.

Authors:  Andrew C Tiu; Jian Yang; Laureano D Asico; Prasad Konkalmatt; Xiaoxu Zheng; Santiago Cuevas; Xiaoyan Wang; Hewang Lee; Momina Mazhar; Robin A Felder; Pedro A Jose; Van Anthony M Villar
Journal:  FASEB J       Date:  2020-04-07       Impact factor: 5.191

Review 6.  Pathogenesis of Skin Injury of Systemic Lupus Erythematosus.

Authors:  Guo-Min Deng
Journal:  Curr Rheumatol Rep       Date:  2018-02-21       Impact factor: 4.592

Review 7.  Lipid rafts in immune signalling: current progress and future perspective.

Authors:  Pallavi Varshney; Vikas Yadav; Neeru Saini
Journal:  Immunology       Date:  2016-07-11       Impact factor: 7.397

Review 8.  T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.

Authors:  Vaishali R Moulton; George C Tsokos
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

9.  Biomarkers in systemic lupus erythematosus: challenges and prospects for the future.

Authors:  Chau-Ching Liu; Amy H Kao; Susan Manzi; Joseph M Ahearn
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-08       Impact factor: 5.346

10.  Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone mice.

Authors:  Guo-Min Deng; Lena Liu; Frances Rena Bahjat; Polly R Pine; George C Tsokos
Journal:  Arthritis Rheum       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.